Prognostic Value of Nuclear FBI-1 in Patients with Rectal Cancer with or Without Preoperative Radiotherapy

Overview

Journal Oncol Lett

Specialty Oncology

Date 2019 Oct 16

PMID 31612040

Citations 1

Authors

Chao-Jie Wang

Chu-Rui Chao

Hui-Min Liu

Yan-Yan Zhu

Gunnar Adell

Ingvar Jarlsfelt

Hong Zhang

Xiao-Feng Sun

Affiliations

Soon will be listed here.

Abstract

Factor that binds to the inducer of short transcripts of the human immunodeficiency virus-1 (FBI-1) represents as a crucial gene regulator in colorectal cancer; however, the correlation between FBI-1 and preoperative radiotherapy (RT) in rectal cancer (RC) has not yet been reported. The aim was to detect FBI-1 expression in patients with RC with or without RT, by immunohistochemistry and quantitative polymerase chain reaction, and to analyze its association with clinicopathological features and response to RT. The results from immunohistochemistry analysis (n=139) and reverse transcription-quantitative polymerase chain reaction (n=55) demonstrated that FBI-1 was overexpressed in patients with RC, whether they had received preoperative RT or not. Subsequently, the association between FBI-1 expression, and the clinicopathological features and response to RT in patients with RC was analyzed. Cytoplasmic FBI-1 was upregulated in non-RT (n=77) and RT (n=62) groups (17.7 vs. 74.0%, P<0.001; 41.1 vs. 69.4%, P=0.002, respectively) of patients with RC compared with normal mucosa. However, nuclear FBI-1 was downregulated (75.8 vs. 22.1%, P<0.001; 83.9 vs. 35.5%, P<0.001, respectively) in both groups. RT had no significant effect on FBI-1 expression in RC tissues. Furthermore, nuclear FBI-1 was positively associated with tumor-node-metastasis stage and distant recurrence (P=0.003 and P=0.010, respectively). In patients with stage I, II or III RC, higher nuclear FBI-1 expression was associated with poorer disease-free survival [hazard ratio (HR)=1.934, 95% confidence interval (CI): 1.055-3.579, P=0.033] and overall survival (HR=2.174, 95% CI: 1.102-4.290, P=0.025), independently of sex, age, growth pattern, differentiation and RT. In addition, FBI-1 was positively correlated with numerous biological factors, including p73 [Spearman's correlation coefficient (r)=0.332, P=0.007], lysyl oxidase (r=0.234, P=0.043), Wrap53 (r=-0.425, P=0.0002) and peroxisome proliferator-activated receptor δ (r=-0.294, P=0.026). In conclusion, the present study demonstrated that nuclear FBI-1 was an independent prognostic factor in patients with RC and correlated with numerous biological factors, which indicated that it may have multiple roles in RC.

Citing Articles

Recent Advancements, Limitations, and Future Perspectives of the use of Personalized Medicine in Treatment of Colon Cancer.

Dey A, Mitra A, Pathak S, Prasad S, Sun Zhang A, Zhang H Technol Cancer Res Treat. 2023; 22:15330338231178403.

PMID: 37248615 PMC: 10240881. DOI: 10.1177/15330338231178403.

References

Maeda T, Hobbs R, Merghoub T, Guernah I, Zelent A, Cordon-Cardo C . Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature. 2005; 433(7023):278-85. DOI: 10.1038/nature03203. View

Jiang L, Siu M, Wong O, Tam K, Lam E, Ngan H . Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancers. Mol Cancer. 2010; 9:318. PMC: 3022670. DOI: 10.1186/1476-4598-9-318. View

Yang Y, Li Y, Di F, Cui J, Wang Y, Xu Z . Pokemon decreases the transcriptional activity of RARα in the absence of ligand. Biol Chem. 2016; 398(3):331-340. DOI: 10.1515/hsz-2016-0142. View

Yang L, Zhang H, Zhou Z, Yan H, Adell G, Sun X . Biological function and prognostic significance of peroxisome proliferator-activated receptor δ in rectal cancer. Clin Cancer Res. 2011; 17(11):3760-70. DOI: 10.1158/1078-0432.CCR-10-2779. View

Zhang H, Wang D, Adell G, Sun X . WRAP53 is an independent prognostic factor in rectal cancer- a study of Swedish clinical trial of preoperative radiotherapy in rectal cancer patients. BMC Cancer. 2012; 12:294. PMC: 3504514. DOI: 10.1186/1471-2407-12-294. View

Yang Y, Cui J, Xue F, Zhang C, Mei Z, Wang Y . Pokemon (FBI-1) interacts with Smad4 to repress TGF-β-induced transcriptional responses. Biochim Biophys Acta. 2014; 1849(3):270-81. DOI: 10.1016/j.bbagrm.2014.12.008. View

Zhu M, Li M, Zhang F, Feng F, Chen W, Yang Y . FBI-1 enhances ETS-1 signaling activity and promotes proliferation of human colorectal carcinoma cells. PLoS One. 2014; 9(5):e98041. PMC: 4032333. DOI: 10.1371/journal.pone.0098041. View

Tamas K, Walenkamp A, de Vries E, van Vugt M, Beets-Tan R, van Etten B . Rectal and colon cancer: Not just a different anatomic site. Cancer Treat Rev. 2015; 41(8):671-9. DOI: 10.1016/j.ctrv.2015.06.007. View

Sartini D, Lo Muzio L, Morganti S, Pozzi V, Di Ruscio G, Rocchetti R . Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis. Oral Dis. 2014; 21(4):462-9. DOI: 10.1111/odi.12304. View

10.

Aggarwal H, Aggarwal A, Hunter 3rd W, Yohannes P, Khan A, Agrawal D . Expression of leukemia/lymphoma related factor (LRF/Pokemon) in human benign prostate hyperplasia and prostate cancer. Exp Mol Pathol. 2011; 90(2):226-30. DOI: 10.1016/j.yexmp.2011.01.003. View

11.

De Rosa M, Pace U, Rega D, Costabile V, Duraturo F, Izzo P . Genetics, diagnosis and management of colorectal cancer (Review). Oncol Rep. 2015; 34(3):1087-96. PMC: 4530899. DOI: 10.3892/or.2015.4108. View

12.

Mak V, Wong O, Siu M, Wong E, Ng W, Wong R . FBI-1 Is Overexpressed in Gestational Trophoblastic Disease and Promotes Tumor Growth and Cell Aggressiveness of Choriocarcinoma via PI3K/Akt Signaling. Am J Pathol. 2015; 185(7):2038-48. DOI: 10.1016/j.ajpath.2015.03.011. View

13.

Liu N, Cox T, Cui W, Adell G, Holmlund B, Ping J . Nuclear expression of lysyl oxidase enzyme is an independent prognostic factor in rectal cancer patients. Oncotarget. 2017; 8(36):60015-60024. PMC: 5601118. DOI: 10.18632/oncotarget.9623. View

14.

Wang X, Zheng B, Lu X, Bai R, Feng L, Wang Q . Preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer: Meta-analysis with trial sequential analysis of long-term survival data. PLoS One. 2018; 13(7):e0200142. PMC: 6042715. DOI: 10.1371/journal.pone.0200142. View

15.

Kong J, Liu X, Li X, Wu J, Wu N, Chen J . Pokemon promotes the invasiveness of hepatocellular carcinoma by enhancing MEF2D transcription. Hepatol Int. 2016; 10(3):493-500. DOI: 10.1007/s12072-015-9697-y. View

16.

Pfeifer D, Gao J, Adell G, Sun X . Expression of the p73 protein in rectal cancers with or without preoperative radiotherapy. Int J Radiat Oncol Biol Phys. 2006; 65(4):1143-8. DOI: 10.1016/j.ijrobp.2006.02.028. View

17.

Lin C, Zhou J, Liu Y, Liu J, Yang X, Jazag A . The silencing of Pokemon attenuates the proliferation of hepatocellular carcinoma cells in vitro and in vivo by inhibiting the PI3K/Akt pathway. PLoS One. 2013; 7(12):e51916. PMC: 3530584. DOI: 10.1371/journal.pone.0051916. View

18.

Kim S, Yu K, Shin K, Kwon K, Hwang T, Kwon O . Low-dose radiation suppresses Pokemon expression under hypoxic conditions. Z Naturforsch C J Biosci. 2014; 69(1-2):68-74. DOI: 10.5560/znc.2013-0035. View

19.

Zhao Z, Wang S, Yu L, Wang J, Chang H, Yan W . Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Lung Cancer. 2008; 62(1):113-9. DOI: 10.1016/j.lungcan.2008.02.014. View

20.

Yi T, Wang P . [The Expression of Pokemon in Endometrial Carcinoma Tissue and the Correlation with Mutant p53]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2016; 47(3):321-5. View